S. 652 — 119th Congress
Federal bill
Protecting Patients from Deceptive Drug Ads Act
- Title
- Protecting Patients from Deceptive Drug Ads Act
- Official title
- A bill to provide for the regulation of certain communications regarding prescription drugs.
- Type
- Senate bill
- Congress
- 119th Congress
- Chamber of origin
- Senate
- Introduced
- 2025-02-20
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S1129-1130)
- Latest action date
- 2025-02-20
Organizations that named this bill in federal lobbying filings
- AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) Federal lobbying client (LDA)
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA Federal lobbying client (LDA)
- GSK (FKA GLAXOSMITHKLINE INC.) Federal lobbying client (LDA)
- PUBLIC CITIZEN Federal lobbying client (LDA)
- AMERICAN ACADEMY OF PEDIATRICS Federal lobbying client (LDA)
Federal lobbying filings naming this bill
U.S. Senate Lobbying Disclosure Act database. A filing names bills, issues and agencies — never the member lobbied — so these rows point only at the client organization, and none of them says any member of Congress was lobbied about this bill. The count is filings in this site's LDA slice, not the
- AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) cited in the filing's issue text 6 filings
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA cited in the filing's issue text 6 filings
- GSK (FKA GLAXOSMITHKLINE INC.) cited in the filing's issue text 4 filings
- PUBLIC CITIZEN cited in the filing's issue text 2 filings
- AMERICAN ACADEMY OF PEDIATRICS cited in the filing's issue text 1 filing